Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, C. Allison Stewart et al.|Cancer Cell|2021Cited by 930
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upHumam Kadara, Roy S. Herbst, Murim Choi et al.|Annals of Oncology|2016Cited by 209
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA networkXiaochao Tan, Jonathan M. Kurie, Priyam Banerjee et al.|Journal of Clinical Investigation|2018Cited by 72
Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma DevelopmentWarapen Treekitkarnmongkol, Humam Kadara, Shanshan Deng et al.|American Journal of Respiratory and Critical Care Medicine|2020Cited by 46
Comparative Functional Genomics Analysis of NNK Tobacco-Carcinogen Induced Lung Adenocarcinoma Development in Gprc5a-Knockout MiceJunya Fujimoto, Reuben Lotan|PLoS ONE|2010Cited by 40